Cunningham Ann Michelle 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 14, 2019
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-01-10+25,000→ 25,000 totalExercise: $1.74Exp: 2029-01-10→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option reported herein will vest ratably, on a monthly basis, beginning on the date of issuance until March 31, 2019.